Tadalista: Advanced Tadalafil Therapy for Erectile Dysfunction
| Product dosage: 10mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.20 | $36.12 (0%) | 🛒 Add to cart |
| 60 | $1.12 | $72.24 $67.08 (7%) | 🛒 Add to cart |
| 90 | $0.98 | $108.36 $88.58 (18%) | 🛒 Add to cart |
| 120 | $0.86 | $144.48 $103.20 (29%) | 🛒 Add to cart |
| 180 | $0.79 | $216.72 $142.76 (34%) | 🛒 Add to cart |
| 270 | $0.74 | $325.08 $199.52 (39%) | 🛒 Add to cart |
| 360 | $0.69
Best per pill | $433.44 $247.68 (43%) | 🛒 Add to cart |
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.46 | $43.86 (0%) | 🛒 Add to cart |
| 60 | $1.38 | $87.72 $82.56 (6%) | 🛒 Add to cart |
| 90 | $1.29 | $131.58 $116.10 (12%) | 🛒 Add to cart |
| 120 | $1.12 | $175.44 $134.16 (24%) | 🛒 Add to cart |
| 180 | $1.03 | $263.16 $185.76 (29%) | 🛒 Add to cart |
| 270 | $0.92 | $394.74 $248.54 (37%) | 🛒 Add to cart |
| 360 | $0.82
Best per pill | $526.32 $294.12 (44%) | 🛒 Add to cart |
| Product dosage: 40mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 20 | $1.85 | $36.98 (0%) | 🛒 Add to cart |
| 30 | $1.72 | $55.47 $51.60 (7%) | 🛒 Add to cart |
| 60 | $1.55 | $110.94 $92.88 (16%) | 🛒 Add to cart |
| 90 | $1.38 | $166.41 $123.84 (26%) | 🛒 Add to cart |
| 120 | $1.29 | $221.88 $154.80 (30%) | 🛒 Add to cart |
| 180 | $1.22 | $332.82 $220.16 (34%) | 🛒 Add to cart |
| 270 | $1.12 | $499.23 $301.86 (40%) | 🛒 Add to cart |
| 360 | $0.99
Best per pill | $665.64 $356.04 (47%) | 🛒 Add to cart |
Tadalista is a high-quality, generic pharmaceutical product containing Tadalafil as its active pharmaceutical ingredient. It is specifically formulated for the treatment of erectile dysfunction (ED) in adult males, offering a reliable and clinically proven solution. This medication belongs to the class of phosphodiesterase type 5 (PDE5) inhibitors, which work by increasing blood flow to the penile tissues during sexual stimulation, thereby facilitating the achievement and maintenance of an erection suitable for satisfactory sexual activity. Manufactured under strict quality control standards, Tadalista provides a therapeutically equivalent alternative to brand-name options, ensuring both efficacy and safety for prescribed use.
Features
- Active Ingredient: Tadalafil 5mg, 10mg, 20mg, or 40mg per tablet
- Pharmaceutical Class: Selective phosphodiesterase type 5 (PDE5) inhibitor
- Onset of Action: Typically within 30–60 minutes post-administration
- Duration of Effect: Up to 36 hours, allowing for spontaneous sexual activity
- Formulation: Film-coated tablets for oral administration
- Excipients: Includes lactose, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate
- Packaging: Blister packs in quantities of 10, 20, or 30 tablets
- Storage Requirements: Room temperature (15–30°C), protected from light and moisture
- Manufacturer Compliance: Produced in facilities adhering to Good Manufacturing Practice (GMP)
- Bioequivalence: Demonstrated comparable pharmacokinetic profile to reference listed drug
Benefits
- Enables reliable achievement and maintenance of erections sufficient for sexual intercourse
- Provides an extended window of effectiveness, reducing time-sensitive pressure and supporting spontaneity
- Supports improved sexual confidence and relationship satisfaction through effective ED management
- Offers a cost-effective therapeutic alternative without compromising on quality or clinical performance
- Backed by extensive clinical data affirming its safety and efficacy profile
- Facilitates adherence to treatment due to simple, as-needed dosing regimen
Common use
Tadalista is indicated for the management of erectile dysfunction, a condition characterized by the consistent inability to attain or maintain a penile erection sufficient for satisfactory sexual performance. It is suitable for adult males experiencing ED of various etiologies, including vasculogenic, neurogenic, and psychogenic origins. The medication is intended for use prior to anticipated sexual activity and requires sexual stimulation to produce its intended effect. It is not indicated for use in women, pediatric populations, or individuals without a diagnosis of erectile dysfunction.
Dosage and direction
The recommended starting dose for most patients is 10 mg taken orally approximately 30–60 minutes before anticipated sexual activity. Based on efficacy and tolerability, the dose may be increased to 20 mg or decreased to 5 mg. The maximum recommended dosing frequency is once per 24-hour period. Tablets should be swallowed whole with a glass of water; they may be taken with or without food, though high-fat meals may delay onset of action. For some patients, a lower daily dose (2.5 mg or 5 mg) may be prescribed for continuous therapy. Dosage adjustments are necessary in patients with renal or hepatic impairment, as detailed in the full prescribing information.
Precautions
Prior to initiating therapy with Tadalista, a thorough medical assessment should be conducted to evaluate cardiovascular status, as sexual activity carries potential cardiac risk. Use with caution in patients with anatomical penile deformity, conditions predisposing to priapism, bleeding disorders, or active peptic ulceration. Patients should be advised that Tadalista offers no protection against sexually transmitted diseases. Concomitant use with other erectile dysfunction treatments is contraindicated. Avoid consumption of grapefruit or grapefruit juice during therapy, as it may increase Tadalafil concentrations. Alcohol in moderation is generally acceptable, though excessive consumption may increase risk of orthostatic hypotension.
Contraindications
Tadalista is contraindicated in patients with known hypersensitivity to Tadalafil or any excipient in the formulation. Concomitant administration with organic nitrates or nitric oxide donors in any form is absolutely contraindicated due to the risk of profound hypotension. It is also contraindicated in patients using guanylate cyclase stimulators. Severe hepatic impairment (Child-Pugh Class C) prohibits use. Patients with unstable angina, recent myocardial infarction, uncontrolled hypertension or hypotension, history of stroke, or severe cardiac failure should not use this medication. Retinal disorders such as retinitis pigmentosa may also represent a contraindication.
Possible side effect
The most commonly reported adverse reactions include headache, dyspepsia, back pain, myalgia, nasal congestion, flushing, and dizziness. These are generally mild to moderate in severity and transient. Less frequently reported effects include visual disturbances, palpitations, gastroesophageal reflux, and limb pain. Priapism (prolonged and painful erection lasting more than 4 hours) is a rare but serious adverse event requiring immediate medical intervention to avoid permanent tissue damage. Sudden hearing loss or non-arteritic anterior ischemic optic neuropathy have been reported in temporal association with PDE5 inhibitor use, though causal relationship remains uncertain.
Drug interaction
Concomitant use with nitrates results in potentiated hypotensive effects and is contraindicated. Alpha-adrenergic blockers may enhance the blood pressure-lowering effects; concomitant administration requires careful titration and monitoring. CYP3A4 inhibitors (e.g., ketoconazole, ritonavir, erythromycin) can increase Tadalafil exposure, necessitating dose adjustment. Inducers of CYP3A4 (e.g., rifampin, phenobarbital) may decrease Tadalafil concentrations. Antihypertensive agents may have additive effects on blood pressure. Grapefruit juice inhibits CYP3A4 metabolism and should be avoided.
Missed dose
As Tadalista is prescribed for use prior to anticipated sexual activity on an as-needed basis, the concept of a “missed dose” does not apply in the traditional sense. Patients should simply take the tablet when needed, ensuring adherence to the maximum once-daily dosing frequency. For patients on daily dosing regimens, if a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped. Doubling of doses is not recommended.
Overdose
In cases of suspected overdose, standard supportive measures should be employed. The most likely manifestations would be an extension of the drug’s known vasodilatory properties, including severe headache, flushing, hypotension, dizziness, and potentially syncope. Hemodynamic support with intravenous fluids and vasopressors may be required for severe hypotension. Dialysis is not expected to significantly enhance elimination due to high protein binding and extensive tissue distribution. Priapism should be managed urgently with corporal aspiration and irrigation if necessary.
Storage
Store at room temperature between 15–30°C (59–86°F). Protect from light and moisture. Keep in the original blister packaging until time of use. Do not store in bathrooms or other areas with high humidity. Keep out of reach of children and pets. Do not use beyond the expiration date printed on the packaging. Properly dispose of any unused or expired medication according to local regulations.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Tadalista is a prescription medication that should only be used under the supervision of a qualified healthcare professional. Patients must consult with their physician for proper diagnosis and treatment recommendations. Individual results may vary based on health status and adherence to prescribing instructions. The manufacturer is not liable for any adverse outcomes resulting from improper use, self-diagnosis, or failure to seek appropriate medical consultation.
Reviews
Clinical studies demonstrate that Tadalafil 20mg produced improvements in erectile function in 81% of patients versus 35% for placebo. Patient satisfaction surveys indicate 76% of men reported improved ability to achieve and maintain an erection suitable for intercourse. In long-term extension studies, 89% of attempted sexual activities were successful with Tadalafil treatment. Real-world evidence supports maintained efficacy with continued use and high treatment satisfaction rates regarding both effectiveness and duration of action. The safety profile remains consistent with the known pharmacology of PDE5 inhibitors.